CFDE Data Portal | Search CES1P1

	Label	Description
	CES1P1 associations Collection (Entity type)	Associations for CES1P1_associations
	CES1P1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CES1P1 Gene (Entity type)	ENSG00000291109 - carboxylesterase 1 pseudogene 1
	GSE146358 dopamine 5 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE198930 prunetin AGS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE207499 sphingosine 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182710 Drp1 TFAM overexpression 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 11 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 6 v 14 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 7 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

CES1P1 associations

Associations for CES1P1_associations

CES1P1 associations.tsv

A file from IDG as part of the Harmonizome project

CES1P1

ENSG00000291109 - carboxylesterase 1 pseudogene 1

GSE146358 dopamine 5 v 1 human up

A Gene Set from LINCS

GSE198930 prunetin AGS 1 v 0 human dn

A Gene Set from LINCS

GSE207499 sphingosine 1 v 0 human up

A Gene Set from LINCS

GSE182710 Drp1 TFAM overexpression 1 v 2 human dn

A Gene Set from LINCS

GSE252944 AKT inhibition 11 v 4 human up

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 6 v 14 human dn

A Gene Set from LINCS

GSE239844 crizotinib 7 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.